250 ML lidocaine hydrochloride 8 MG/ML Injection — RxCUI 1737723
RxNorm drug concept · Semantic clinical drug
RxCUI 1737723
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1737723
Official name250 ML lidocaine hydrochloride 8 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine HCl 2 GM per 250 ML Injection; lidocaine HCl 0.8 % in 250 ML Injection; lidocaine HCl 0.8 % per 250 ML Injection
FDA products mapped6
Package NDCs mapped7
Reported Medicaid activity (SDUD)1,606 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How 250 ML lidocaine hydrochloride 8 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
250 ML lidocaine hydrochloride 8 MG/ML Injection
RxCUI 1737723 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Lidocaine hydrochloride
142440PIN
-
Lidocaine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Injection
1737342SCDF -
Lidocaine hydrochloride Injection
2646960SCDFP -
Lidocaine Injectable Product
1164658SCDG -
Lidocaine hydrochloride Injectable Product
2663499SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Lidocaine Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine hydrochloride 8 MG/ML
1011251SCDC
-
Lidocaine hydrochloride 8 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine hydrochloride 8 MG/ML
SCDC · 1011251 -
Lidocaine Injection
SCDF · 1737342 -
Lidocaine hydrochloride Injection
SCDFP · 2646960 -
Lidocaine Injectable Product
SCDG · 1164658 -
Lidocaine hydrochloride Injectable Product
SCDGP · 2663499
📦 FDA Products & Package NDCs
6 products · 7 package NDCs
7 package NDCs map to RxCUI 1737723 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00264-9594-10 | 24 CONTAINER in 1 CASE (0264-9594-10) / 500 mL in 1 CONTAIN... | Lidocaine Hydrochloride and Dextrose | B. Braun Medical Inc. | 1992-04-08 |
| 00264-9594-20 | 24 CONTAINER in 1 CASE (0264-9594-20) / 250 mL in 1 CONTAIN... | Lidocaine Hydrochloride and Dextrose | B. Braun Medical Inc. | 1992-04-08 |
| 00264-9598-20 | 24 CONTAINER in 1 CASE (0264-9598-20) / 250 mL in 1 CONTAIN... | Lidocaine Hydrochloride and Dextrose | B. Braun Medical Inc. | 1992-04-08 |
| 00338-0409-03 | 18 BAG in 1 CARTON (0338-0409-03) / 500 mL in 1 BAG | Lidocaine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1981-04-22 |
| 00338-0411-02 | 24 BAG in 1 CARTON (0338-0411-02) / 250 mL in 1 BAG | Lidocaine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1981-04-22 |
| 51662-1565-01 | 250 mL in 1 CONTAINER (51662-1565-1) | LIDOCAINE HCI AND DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 2021-07-17 |
| 51662-1657-01 | 250 mL in 1 BAG (51662-1657-1) | LIDOCAINE HYDROCHLORIDE AND DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 1981-04-22 |
Observed labelers:
B. Braun Medical Inc. (3) ·
Baxter Healthcare Corporation (2) ·
HF Acquisition Co LLC, DBA HealthFirst (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2002 | Inj, lidocaine in d5w, 1 mg | 5 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.